Joel Greenblatt's position in Bio-Rad Laboratories is currently worth $10.5 Million. That's 0.19% of their equity portfolio (95th largest holding). The first Bio-Rad Laboratories trade was made in Q4 2011. Since then Joel Greenblatt bought shares sixteen more times and sold shares on nineteen occasions. The investor's estimated purchase price is $14.7 Million, resulting in a loss of 29%.